These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36525475)

  • 21. Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration.
    Nakajima T; Yasufuku K; Nakagawara A; Kimura H; Yoshino I
    Chest; 2011 Nov; 140(5):1319-1324. PubMed ID: 21527506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic ultrasound-guided fine needle aspiration and endobronchial ultrasound-guided transbronchial needle aspiration: Are two better than one in mediastinal staging of non-small cell lung cancer?
    Oki M; Saka H; Ando M; Kitagawa C; Kogure Y; Seki Y
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1169-77. PubMed ID: 24930616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sampling Utility of the Convex Probe Endobronchial Ultrasound Visible Intrapulmonary Lesion.
    Almeida FA; Salam S; Mehta AC; Yuhico L; Sarda Y; Choi H; Cicenia JC; Gildea T; Machuzak M; Mazzone P; Oliveira E; Sethi S; Wang XF; Reynolds JP
    J Bronchology Interv Pulmonol; 2018 Oct; 25(4):290-299. PubMed ID: 29901532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conventional Transbronchial Needle Aspiration Versus Endobronchial Ultrasound-guided Transbronchial Needle Aspiration, With or Without Rapid On-Site Evaluation, for the Diagnosis of Sarcoidosis: A Randomized Controlled Trial.
    Madan K; Dhungana A; Mohan A; Hadda V; Jain D; Arava S; Pandey RM; Khilnani GC; Guleria R
    J Bronchology Interv Pulmonol; 2017 Jan; 24(1):48-58. PubMed ID: 27984385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endobronchial ultrasound-guided transbronchial needle aspiration for lung cancer staging: early experience in Brazil.
    Figueiredo VR; Cardoso PF; Jacomelli M; Demarzo SE; Palomino AL; Rodrigues AJ; Terra RM; Pego-Fernandes PM; Carvalho CR
    J Bras Pneumol; 2015; 41(1):23-30. PubMed ID: 25750671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of coexisting gene mutations in EGFR-mutated non-small cell lung cancer before treatment on EGFR T790M mutation status after EGFR-TKIs.
    Takeda M; Sakai K; Hayashi H; Tanaka K; Haratani K; Takahama T; Kato R; Yonesaka K; Nishio K; Nakagawa K
    Lung Cancer; 2020 Jan; 139():28-34. PubMed ID: 31710890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endobronchial ultrasound-guided transbronchial needle aspiration in peripheral pulmonary lesions: a systematic review and meta-analysis.
    Lou L; Huang X; Tu J; Xu Z
    Clin Exp Metastasis; 2023 Feb; 40(1):45-52. PubMed ID: 36401666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration samples for programmed death ligand-1 testing in non-small cell lung cancer, the Bristol experience.
    Hardy J; Bhatt N; Medford ARL
    Asia Pac J Clin Oncol; 2022 Apr; 18(2):e32-e38. PubMed ID: 33870634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adequacy of EBUS-TBNA specimen for mutation analysis of lung cancer.
    Cicek T; Ozturk A; Yılmaz A; Aktas Z; Demirag F; Akyurek N
    Clin Respir J; 2019 Feb; 13(2):92-97. PubMed ID: 30582673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis of peripheral lung adenocarcinoma in brush cytology obtained by EBUS plus fluoroscopy-guided bronchoscopy.
    Sánchez-Font A; Chalela R; Martín-Ontiyuelo C; Albero-González R; Dalmases A; Longarón R; Alonso-Espinaco V; Curull V; Bellosillo B; Pijuan L
    Cancer Cytopathol; 2018 Oct; 126(10):860-871. PubMed ID: 30291816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma.
    Zhang Q; Ke E; Niu F; Deng W; Chen Z; Xu C; Zhang X; Zhao N; Su J; Yang J; Yan H; Wu Y; Zhou Q
    Oncotarget; 2017 Jan; 8(3):4994-5002. PubMed ID: 27999211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between endobronchial ultrasound-guided (EBUS)-transbronchial needle aspiration utility and computed tomography staging, node size at EBUS, and positron emission tomography scan node standard uptake values: A retrospective analysis.
    Marchand C; Medford ARL
    Thorac Cancer; 2017 Jul; 8(4):285-290. PubMed ID: 28436173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rebiopsy for patients with non-small-cell lung cancer after epidermal growth factor receptor-tyrosine kinase inhibitor failure.
    Kawamura T; Kenmotsu H; Taira T; Omori S; Nakashima K; Wakuda K; Ono A; Naito T; Murakami H; Mori K; Nakajima T; Ohde Y; Endo M; Takahashi T
    Cancer Sci; 2016 Jul; 107(7):1001-5. PubMed ID: 27145431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of epidermal growth factor receptor (EGFR) gene T790M mutation by droplet digital PCR and Super-ARMS PCR in plasma ctDNA samples of non-small cell lung cancer patients with the resistance to EGFR-tyrosine kinase inhibitor].
    Cao ZY; Wu W; Hou LK; Zhang W; Gao CX; Wu CY; Zhang LP
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):910-914. PubMed ID: 30522170
    [No Abstract]   [Full Text] [Related]  

  • 35. Endobronchial ultrasound-guided transbronchial needle aspiration for differentiating N0 versus N1 lung cancer.
    Yasufuku K; Nakajima T; Waddell T; Keshavjee S; Yoshino I
    Ann Thorac Surg; 2013 Nov; 96(5):1756-60. PubMed ID: 23953728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer.
    Yu KL; Tsai TH; Ho CC; Liao WY; Lin CK; Hsu CL; Shih JY
    Sci Rep; 2018 Apr; 8(1):5837. PubMed ID: 29643378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Feasibility of assessing EGFR mutation and others using samples obtained by EBUS transbronchial needle aspiration].
    Boulanger S; Delattre C; Descarpentries C; Escande F; Bouchindhomme B; Copin MC; Dhalluin X; Scherpereel A; Ramon PP; Cortot A; Fournier C
    Rev Mal Respir; 2013 May; 30(5):351-6. PubMed ID: 23746811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-biopsy and liquid biopsy for patients with non-small cell lung cancer after EGFR-tyrosine kinase inhibitor failure.
    Zhou J; Zhao C; Zhao J; Wang Q; Chu X; Li J; Zhou F; Ren S; Li X; Su C; Zhou C
    Thorac Cancer; 2019 Apr; 10(4):957-965. PubMed ID: 30887673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors.
    Matsumoto Y; Sawa K; Fukui M; Oyanagi J; Yoshimoto N; Suzumura T; Watanabe T; Kaneda H; Mitsuoka S; Asai K; Kimura T; Yamamoto N; Hirata K; Koh Y; Kawaguchi T
    Lung Cancer; 2020 Jan; 139():80-88. PubMed ID: 31751804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies.
    Uozu S; Imaizumi K; Yamaguchi T; Goto Y; Kawada K; Minezawa T; Okamura T; Akao K; Hayashi M; Isogai S; Okazawa M; Hashimoto N; Hasegawa Y
    BMC Pulm Med; 2017 Dec; 17(1):175. PubMed ID: 29212495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.